Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism1
Open Access
- 1 October 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (4) , 1196-1207
- https://doi.org/10.1046/j.1523-1755.2002.00585.x
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- p21WAF1 and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth1Kidney International, 2001
- Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia.Journal of Clinical Investigation, 1995
- Calcium Modulates the Cyclin D1 Expression in a Rat Parathyroid Cell LineBiochemical and Biophysical Research Communications, 1994
- Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriolKidney International, 1994
- Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissueWorld Journal of Surgery, 1992
- Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysisKidney International, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- Monoclonality and Abnormal Parathyroid Hormone Genes in Parathyroid AdenomasNew England Journal of Medicine, 1988
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984